C90.22

Clinical Causes: Recurrence of multiple myeloma that originally involved plasma cells in the bone marrow, which later infiltrate extramedullary sites Incomplete eradication of cancer cells during initial therapy, allowing residual disease to develop into relapse Genetic mutations within plasma cells that confer resistance to treatments and promote spreading outside the marrow Immunosuppressive factors that weaken the body's ability to control abnormal plasma cell growth Environmental or genetic predispositions that increase vulnerability to plasma cell malignancies

Key Symptoms: Localized swelling or mass in soft tissues such as the head, neck, or other affected regions Unexplained pain or discomfort associated with the tumor site Nasal congestion or sinus issues if the plasmacytoma occurs in the nasal cavity Difficulty breathing or swallowing in cases involving the airway or throat Neurological symptoms if the tumor compresses nerves or the spinal cord General fatigue or weight loss in some cases

Diagnosis Path: Physical examination focusing on the affected area for swelling or masses Imaging studies such as MRI, CT scans, or PET scans to identify the location and size of the tumor Biopsy of the lesion to confirm the diagnosis, revealing monoclonal plasma cell proliferation Laboratory tests including blood work to evaluate overall health and identify abnormal proteins Bone marrow examination to assess the extent of plasma cell involvement and rule out systemic disease

Treatment Protocols: Radiation therapy to target and eliminate localized extramedullary masses Chemotherapy regimens tailored to the patient's condition, aiming to control further spread Immunotherapy approaches to boost the body's ability to fight plasma cell proliferation Targeted therapies focusing on specific genetic mutations in the tumor cells Surgical removal of accessible masses when feasible Supportive care to manage symptoms and maintain quality of life